This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armesilla, A. L.
Right arrow Articles by Redondo, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armesilla, A. L.
Right arrow Articles by Redondo, J. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 1999, p. 2032-2043, Vol. 19, No. 3
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Vascular Endothelial Growth Factor Activates Nuclear Factor of Activated T Cells in Human Endothelial Cells: a Role for Tissue Factor Gene Expression

Angel Luis Armesilla,1,2 Elisa Lorenzo,1 Pablo Gómez del Arco,1 Sara Martínez-Martínez,1 Arantzazu Alfranca,2 and Juan Miguel Redondo1,*

Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid, Facultad de Ciencias, Cantoblanco, Madrid 28049,1 and Servicio de Inmunología, Hospital de la Princesa, Madrid 28006,2 Spain

Received 25 June 1998/Returned for modification 11 September 1998/Accepted 12 November 1998

Vascular endothelial growth factor (VEGF) is a potent angiogenic inducer that stimulates the expression of tissue factor (TF), the major cellular initiator of blood coagulation. Here we show that signaling triggered by VEGF induced DNA-binding and transcriptional activities of nuclear factor of activated T cells (NFAT) and AP-1 in human umbilical vein endothelial cells (HUVECs). VEGF also induced TF mRNA expression and gene promoter activation by a cyclosporin A (CsA)-sensitive mechanism. As in lymphoid cells, NFAT was dephosphorylated and translocated to the nucleus upon activation of HUVECs, and these processes were blocked by CsA. NFAT was involved in the VEGF-mediated TF promoter activation as evidenced by cotransfection experiments with a dominant negative version of NFAT and site-directed mutagenesis of a newly identified NFAT site within the TF promoter that overlaps with a previously identified kappa B-like site. Strikingly, this site bound exclusively NFAT not only from nuclear extracts of HUVECs activated by VEGF, a stimulus that failed to induce NF-kappa B-binding activity, but also from extracts of cells activated with phorbol esters and calcium ionophore, a combination of stimuli that triggered the simultaneous activation of NFAT and NF-kappa B. These results implicate NFAT in the regulation of endothelial genes by physiological means and shed light on the mechanisms that switch on the gene expression program induced by VEGF and those regulating TF gene expression.

* Corresponding author. Mailing address: Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid. Facultad de Ciencias, Cantoblanco, Madrid 28049, Spain. Phone: 34-91-397-4252. Fax: 34-91-397-4799. E-mail: jmredondo{at}cbm.uam.es.

Molecular and Cellular Biology, March 1999, p. 2032-2043, Vol. 19, No. 3
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Maitra, U., Parks, J. S., Li, L. (2009). An Innate Immunity Signaling Process Suppresses Macrophage ABCA1 Expression through IRAK-1-Mediated Downregulation of Retinoic Acid Receptor {alpha} and NFATc2. Mol. Cell. Biol. 29: 5989-5997 [Abstract] [Full Text]  
  • Combs, M. D., Yutzey, K. E. (2009). VEGF and RANKL Regulation of NFATc1 in Heart Valve Development. Circ. Res. 105: 565-574 [Abstract] [Full Text]  
  • Maiti, D., Xu, Z., Duh, E. J. (2008). Vascular Endothelial Growth Factor Induces MEF2C and MEF2-Dependent Activity in Endothelial Cells. IOVS 49: 3640-3648 [Abstract] [Full Text]  
  • Gaudel, C., Schwartz, C., Giordano, C., Abumrad, N. A., Grimaldi, P. A. (2008). Pharmacological activation of PPAR{beta} promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 295: E297-E304 [Abstract] [Full Text]  
  • Staton, C. A, Chetwood, A. S A, Cameron, I. C, Cross, S. S, Brown, N. J, Reed, M. W R (2007). The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut 56: 1426-1432 [Abstract] [Full Text]  
  • Wagner, M., Siddiqui, M. A. Q. (2007). Signal Transduction in Early Heart Development (II): Ventricular Chamber Specification, Trabeculation, and Heart Valve Formation. Exp. Biol. Med. 232: 866-880 [Abstract] [Full Text]  
  • Stannard, A. K., Khurana, R., Evans, I. M., Sofra, V., Holmes, D. I.R., Zachary, I. (2007). Vascular Endothelial Growth Factor Synergistically Enhances Induction of E-Selectin by Tumor Necrosis Factor-{alpha}. Arterioscler. Thromb. Vasc. Bio. 27: 494-502 [Abstract] [Full Text]  
  • Zimman, A., Mouillesseaux, K. P., Le, T., Gharavi, N. M., Ryvkin, A., Graeber, T. G., Chen, T. T., Watson, A. D., Berliner, J. A. (2007). Vascular Endothelial Growth Factor Receptor 2 Plays a Role in the Activation of Aortic Endothelial Cells by Oxidized Phospholipids. Arterioscler. Thromb. Vasc. Bio. 27: 332-338 [Abstract] [Full Text]  
  • Brinkmann, M. M., Pietrek, M., Dittrich-Breiholz, O., Kracht, M., Schulz, T. F. (2007). Modulation of Host Gene Expression by the K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus. J. Virol. 81: 42-58 [Abstract] [Full Text]  
  • Qin, L., Zhao, D., Liu, X., Nagy, J. A., Hoang, M. V., Brown, L. F., Dvorak, H. F., Zeng, H. (2006). Down Syndrome Candidate Region 1 Isoform 1 Mediates Angiogenesis through the Calcineurin-NFAT Pathway. Mol Cancer Res 4: 811-820 [Abstract] [Full Text]  
  • Hamik, A., Wang, B., Jain, M. K. (2006). Transcriptional Regulators of Angiogenesis. Arterioscler. Thromb. Vasc. Bio. 26: 1936-1947 [Abstract] [Full Text]  
  • Cano, E., Canellada, A., Minami, T., Iglesias, T., Redondo, J. M. (2005). Depolarization of Neural Cells Induces Transcription of the Down Syndrome Critical Region 1 Isoform 4 via a Calcineurin/Nuclear Factor of Activated T Cells-dependent Pathway. J. Biol. Chem. 280: 29435-29443 [Abstract] [Full Text]  
  • Pi, X., Garin, G., Xie, L., Zheng, Q., Wei, H., Abe, J.-i., Yan, C., Berk, B. C. (2005). BMK1/ERK5 Is a Novel Regulator of Angiogenesis by Destabilizing Hypoxia Inducible Factor 1{alpha}. Circ. Res. 96: 1145-1151 [Abstract] [Full Text]  
  • Li, W., Kessler, P., Yeger, H., Alami, J., Reeve, A. E., Heathcott, R., Skeen, J., Williams, B. R.G. (2005). A Gene Expression Signature for Relapse of Primary Wilms Tumors. Cancer Res. 65: 2592-2601 [Abstract] [Full Text]  
  • Minami, T., Horiuchi, K., Miura, M., Abid, Md. R., Takabe, W., Noguchi, N., Kohro, T., Ge, X., Aburatani, H., Hamakubo, T., Kodama, T., Aird, W. C. (2004). Vascular Endothelial Growth Factor- and Thrombin-induced Termination Factor, Down Syndrome Critical Region-1, Attenuates Endothelial Cell Proliferation and Angiogenesis. J. Biol. Chem. 279: 50537-50554 [Abstract] [Full Text]  
  • Kiani, A., Habermann, I., Haase, M., Feldmann, S., Boxberger, S., Sanchez-Fernandez, M. A., Thiede, C., Bornhauser, M., Ehninger, G. (2004). Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation. J. Leukoc. Biol. 76: 1057-1065 [Abstract] [Full Text]  
  • Mason, J. C., Steinberg, R., Lidington, E. A., Kinderlerer, A. R., Ohba, M., Haskard, D. O. (2004). Decay-accelerating Factor Induction on Vascular Endothelium by Vascular Endothelial Growth Factor (VEGF) Is Mediated via a VEGF Receptor-2 (VEGF-R2)- and Protein Kinase C-{alpha}/{epsilon} (PKC{alpha}/{epsilon})-dependent Cytoprotective Signaling Pathway and Is Inhibited by Cyclosporin A. J. Biol. Chem. 279: 41611-41618 [Abstract] [Full Text]  
  • van Weel, V., Deckers, M. M.L., Grimbergen, J. M., van Leuven, K. J.M., Lardenoye, J. H.P., Schlingemann, R. O., van Nieuw Amerongen, G. P., van Bockel, J. H., van Hinsbergh, V. W.M., Quax, P. H.A. (2004). Vascular Endothelial Growth Factor Overexpression in Ischemic Skeletal Muscle Enhances Myoglobin Expression In Vivo. Circ. Res. 95: 58-66 [Abstract] [Full Text]  
  • Hesser, B. A., Liang, X. H., Camenisch, G., Yang, S., Lewin, D. A., Scheller, R., Ferrara, N., Gerber, H.-P. (2004). Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood 104: 149-158 [Abstract] [Full Text]  
  • Zaichuk, T. A., Shroff, E. H., Emmanuel, R., Filleur, S., Nelius, T., Volpert, O. V. (2004). Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and Inhibition. JEM 199: 1513-1522 [Abstract] [Full Text]  
  • Katzav, S. (2004). Vav1: an oncogene that regulates specific transcriptional activation of T cells. Blood 103: 2443-2451 [Abstract] [Full Text]  
  • Chung, N A, Lydakis, C, Belgore, F, Li-Saw-Hee, F L, Blann, A D, Lip, G Y H (2003). Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease. Heart 89: 1411-1415 [Abstract] [Full Text]  
  • Hogan, P. G., Chen, L., Nardone, J., Rao, A. (2003). Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17: 2205-2232 [Full Text]  
  • Pati, S., Foulke, J. S. Jr., Barabitskaya, O., Kim, J., Nair, B. C., Hone, D., Smart, J., Feldman, R. A., Reitz, M. (2003). Human Herpesvirus 8-Encoded vGPCR Activates Nuclear Factor of Activated T Cells and Collaborates with Human Immunodeficiency Virus Type 1 Tat. J. Virol. 77: 5759-5773 [Abstract] [Full Text]  
  • Lucerna, M., Mechtcheriakova, D., Kadl, A., Schabbauer, G., Schafer, R., Gruber, F., Koshelnick, Y., Muller, H.-D., Issbrucker, K., Clauss, M., Binder, B. R., Hofer, E. (2003). NAB2, a Corepressor of EGR-1, Inhibits Vascular Endothelial Growth Factor-mediated Gene Induction and Angiogenic Responses of Endothelial Cells. J. Biol. Chem. 278: 11433-11440 [Abstract] [Full Text]  
  • Johnson, E. N., Lee, Y. M., Sander, T. L., Rabkin, E., Schoen, F. J., Kaushal, S., Bischoff, J. (2003). NFATc1 Mediates Vascular Endothelial Growth Factor-induced Proliferation of Human Pulmonary Valve Endothelial Cells. J. Biol. Chem. 278: 1686-1692 [Abstract] [Full Text]  
  • Chung, N. A.Y., Belgore, F., Li-Saw-Hee, F. L., Conway, D. S.G., Blann, A. D., Lip, G. Y.H. (2002). Is the Hypercoagulable State in Atrial Fibrillation Mediated by Vascular Endothelial Growth Factor?. Stroke 33: 2187-2191 [Abstract] [Full Text]  
  • Kou, R., Greif, D., Michel, T. (2002). Dephosphorylation of Endothelial Nitric-oxide Synthase by Vascular Endothelial Growth Factor. IMPLICATIONS FOR THE VASCULAR RESPONSES TO CYCLOSPORIN A. J. Biol. Chem. 277: 29669-29673 [Abstract] [Full Text]  
  • Lorenzo, E., Ruiz-Ruiz, C., Quesada, A. J., Hernandez, G., Rodriguez, A., Lopez-Rivas, A., Redondo, J. M. (2002). Doxorubicin Induces Apoptosis and CD95 Gene Expression in Human Primary Endothelial Cells through a p53-dependent Mechanism. J. Biol. Chem. 277: 10883-10892 [Abstract] [Full Text]  
  • Horsley, V., Pavlath, G. K. (2002). Nfat: ubiquitous regulator of cell differentiation and adaptation. JCB 156: 771-774 [Abstract] [Full Text]  
  • Bochkov, V. N., Mechtcheriakova, D., Lucerna, M., Huber, J., Malli, R., Graier, W. F., Hofer, E., Binder, B. R., Leitinger, N. (2002). Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca++/NFAT. Blood 99: 199-206 [Abstract] [Full Text]  
  • Hernandez, G. L., Volpert, O. V., Iniguez, M. A., Lorenzo, E., Martinez-Martinez, S., Grau, R., Fresno, M., Redondo, J. M. (2001). Selective Inhibition of Vascular Endothelial Growth Factor-Mediated Angiogenesis by Cyclosporin a: Roles of the Nuclear Factor of Activated T Cells and Cyclooxygenase 2. JEM 193: 607-620 [Abstract] [Full Text]  
  • Zachary, I., Gliki, G. (2001). Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49: 568-581 [Abstract] [Full Text]  
  • Dor, Y, Camenisch, T., Itin, A, Fishman, G., McDonald, J., Carmeliet, P, Keshet, E (2001). A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development 128: 1531-1538 [Abstract]  
  • MECHTCHERIAKOVA, D., SCHABBAUER, G., LUCERNA, M., CLAUSS, M., DE MARTIN, R., BINDER, B. R., HOFER, E. (2001). Specificity, diversity, and convergence in VEGF and TNF-{alpha} signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. FASEB J. 15: 230-242 [Abstract] [Full Text]  
  • Abbott, K. L., Loss, J. R. II, Robida, A. M., Murphy, T. J. (2000). Evidence That Galpha q-Coupled Receptor-Induced Interleukin-6 mRNA in Vascular Smooth Muscle Cells Involves the Nuclear Factor of Activated T Cells. Mol. Pharmacol. 58: 946-953 [Abstract] [Full Text]  
  • Navarro-Antolin, J., Rey-Campos, J., Lamas, S. (2000). Transcriptional Induction of Endothelial Nitric Oxide Gene by Cyclosporine A. A ROLE FOR ACTIVATOR PROTEIN-1. J. Biol. Chem. 275: 3075-3080 [Abstract] [Full Text]  
  • Blum, S., Issbruker, K., Willuweit, A., Hehlgans, S., Lucerna, M., Mechtcheriakova, D., Walsh, K., von der Ahe, D., Hofer, E., Clauss, M. (2001). An Inhibitory Role of the Phosphatidylinositol 3-Kinase-signaling Pathway in Vascular Endothelial Growth Factor-induced Tissue Factor Expression. J. Biol. Chem. 276: 33428-33434 [Abstract] [Full Text]  
  • Horsley, V., Pavlath, G. K. (2002). Nfat: ubiquitous regulator of cell differentiation and adaptation. JCB 156: 771-774 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»